| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 56.9 | 46.5 | +22.3% |
| EBITDA | 8.3 | 6.4 | +29.0% |
| EBITDA margin | 14.6% | 13.9% | +0.8 pts |
| Profit before tax | 5.5 | 4.5 | +23.8% |
| Net profit | 4.0 | 6.3 | −37.3% |
| EPS | ₹2.05 | ₹1.64 | +25.0% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 |
|---|
| 344 | — | — | |
| 6.7 | 6.7 | 4.3 | |
| 9.8 | 9.8 | 17.4 | |
| 267 | 173 | 156 | |
| — | +10.8% | — | |
| 40.9 | 25.9 | 25.4 | |
| 15.3% | 15.0% | 16.3% | |
| 34.5 | 21.9 | 21.6 | |
| 19.0 | 11.9 | 13.7 | |
| 7.1% | 6.9% | 8.8% | |
| ₹9.85 | ₹6.16 | ₹7.08 | |
| — | −13.0% | — | |
| — | 19.4 | 20.1 | |
| — | −5.8 | −48.3 | |
| 13.7 | 13.7 | −28.2 | |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|
| Market Capitalization | — | — | 343.8 | |
| - Cash, Equiv & ST Investments | 4.3 | 6.7 | 6.7 | |
| + Minority Interest | 17.4 | 9.8 | 9.8 | |
| Revenue | 156.0 | 172.9 | 267.0 | |
| Growth %, YoY | — | +10.8 | — | |
| EBITDA | 25.4 | 25.9 | 40.9 | |
| Margin % | 16.29 | 14.97 | 15.33 | |
| EBIT | 21.6 | 21.9 | 34.5 | |
| Net Income | 13.7 | 11.9 | 19.0 | |
| Margin % | 8.78 | 6.89 | 7.13 | |
| EPS, Adj (current shares) | 7.08 | 6.16 | 9.85 | |
| Growth %, YoY | — | -13.0 | — | |
| Cash from Operations | 20.1 | 19.4 | — | |
| Capital Expenditures | -48.3 | -5.8 | — | |
| Free Cash Flow | -28.2 | 13.7 | 13.7 | |
Prices at the 29 October 2026 close · figures from the company's filings with NSE
QMS Medical Allied Services (NSE: QMSMEDI) had a market capitalisation of ₹343 crore at the 29 October 2026 close (₹177.18 a share) and a PE ratio of 18.3 on the last four quarters' profit. In FY26 its consolidated net profit was ₹11.9 crore on revenue of ₹173 crore; in Q1 FY27 (April–June 2026) it was ₹3.6 crore, down 42.1% year on year. Promoters held 68.11% of the shares on 30 September 2026.
QMS Medical Allied Services' PE ratio is 18.3 at the 29 October 2026 close (₹177.18 a share): a market capitalisation of ₹343 crore divided by consolidated net profit of ₹18.7 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹11.9 crore) it is 28.8.
On 30 September 2026, QMS Medical Allied Services' shares were held by promoters 68.11%, foreign portfolio investors (FII/FPI) 0.41%, domestic institutions (DII) 1.30% and retail and other non-institutional investors 30.17%. Over the year, FII holding was up 0.40 percentage points from 0.01% and DII holding was down 0.30 percentage points from 1.60%.
In FY26, QMS Medical Allied Services generated ₹19.4 crore of cash from operations and spent ₹5.8 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹13.7 crore. In FY25 it was −₹28.2 crore.
QMS Medical Allied Services' market capitalisation was ₹343 crore at the 29 October 2026 close: 1.93 crore shares at ₹177.18 each.
In 2026, QMS Medical Allied Services has declared one dividend: ₹0.50 with record date 23 September 2026.
Promoters held 68.11% of QMS Medical Allied Services on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
QMS Medical Allied Services' basic earnings per share (EPS) were ₹5.40 in FY26, against ₹6.77 in FY25.
In FY26 (April 2025–March 2026), QMS Medical Allied Services' consolidated net profit was ₹11.9 crore, down 13.0% from ₹13.7 crore in FY25, on revenue from operations of ₹173 crore (up 10.8%).
QMS Medical Allied Services has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.
QMS Medical Allied Services' latest results are for Q1 FY27 (April–June 2026), filed on 14 August 2026: consolidated net profit ₹3.6 crore, down 42.1% from ₹6.3 crore in Q1 FY26; revenue from operations ₹56.9 crore, up 22.3% year on year.
From QMS Medical Allied Services' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.